J. W. L. Brown Et Al. , "The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , vol.23, Paris, France, pp.992-994, 2017
Brown, J. W. L. Et Al. 2017. The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 992-994.
Brown, J. W. L., Lugaresi, A., Horakova, D., Havrdova, E., Jokubaitis, V., Lechner-Scott, J., ... Trojano, M.(2017). The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.992-994). Paris, France
Brown, J. Et Al. "The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017
Brown, J. W. Et Al. "The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.992-994, 2017
Brown, J. W. L. Et Al. (2017) . "The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.992-994.
@conferencepaper{conferencepaper, author={J. W. L. Brown Et Al. }, title={The risk of relapse following on-treatment clinically silent lesions in patients with relapsing-remitting multiple sclerosis}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={992-994} }